Press release
Carolyn Compton of NCI to speak at Oncology Biomarkers Conference on Jan 2011 CA
Carolyn Compton, Director of the NCI Office of Biorepositories and Biospecimen Research will give a featured presentation on “Those Biomarkers Come from Biospecimens: Garbage In, Garbage Out” at GTCbio’s 3rd Oncology Biomarkers Conference on January 27-28, 2011 in San Diego, CADr. Compton will discuss how human biospecimens of sufficient quality are the principal sources of molecular data from patients. They are needed to meet the demands of the state-of-the-art analysis technologies that are essential for the accurate identification of molecular targets for drug development, disease diagnosis, and prevention; characterization of biologic variations that determine drug efficacy and drug toxicity; identification of markers for susceptibility, screening, and reoccurrence; development of molecular-based disease taxonomies; elucidation of molecular mechanisms of disease; and validation new therapeutics and diagnostics.
Carolyn Compton, Director of the NCI Office of Biorepositories and Biospecimen Research will give a featured presentation on “Those Biomarkers Come from Biospecimens: Garbage In, Garbage Out” at GTCbio’s 3rd Oncology Biomarkers Conference on January 27-28, 2011 in San Diego, CA
GTCbio
434 W. Foothill Blvd. Monrovia, CA 91016
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Carolyn Compton of NCI to speak at Oncology Biomarkers Conference on Jan 2011 CA here
News-ID: 153041 • Views: …
More Releases for Biospecimen
Global Biospecimen Contract Research Services Market Deep Research Report with F …
InsightAce Analytic Pvt. Ltd. has announced the publication of a market research report titled " Global Biospecimen Contract Research Services Market (By Biospecimen Types(Oncological Studies, FFPE Tissue, Frozen Tissue, Plasma / Serum, Other Biospecimens, Non-Oncological Studies, Blood Products, Human Tissue, Other Biospecimens), Therapeutic Area(Oncological Disorders, Neurological Disorders, Cardiovascular Disorders, Other Therapeutic Areas))- Market Outlook and Industry Analysis 2030"
Get a Demo Sample copy of the Global Biospecimen Contract Research Services…
iSpecimen Inc. Earns Investor Attention After Launching Milestone Cancer Biospec …
On Thursday morning, iSpecimen Inc. (NASDAQ: ISPC) attracted significant investor attention with a 48% premarket jump to $6.60. While momentum eased after the open, ISPC bulls remained in control, ending the day with an impressive 11% gain [https://finance.yahoo.com/quote/ISPC/history/]and trading volume over ten times its usual average. Incidentally, that jump was well-deserved.
Since its 2009 inception, iSpecimen has steadily reshaped how biospecimens are sourced, creating a marketplace model that fills crucial gaps…
iSpecimen Inc. Stock Surges After Announcing Expanded Cancer Biospecimen Offerin …
The premarket surge in iSpecimen Inc. (NASDAQ: ISPC) on Thursday caught the attention of many, with the stock leaping 48% to $6.60 at the early morning's peak. While it moderated slightly after the opening bell, iSpecimen maintained momentum, closing up over 11% [https://finance.yahoo.com/quote/ISPC/history/]amid, a trading volume more than ten times its daily average.
For those familiar with iSpecimen, the jump wasn't entirely unexpected. Since its founding in 2009, iSpecimen has transformed…
Biospecimen Contract Research Services Market Insights: Key Players and Strategi …
InsightAce Analytic Pvt. Ltd. has announced the publication of a market research report titled " Global Biospecimen Contract Research Services Market (By Biospecimen Types(Oncological Studies, FFPE Tissue, Frozen Tissue, Plasma / Serum, Other Biospecimens, Non-Oncological Studies, Blood Products, Human Tissue, Other Biospecimens), Therapeutic Area(Oncological Disorders, Neurological Disorders, Cardiovascular Disorders, Other Therapeutic Areas))- Market Outlook and Industry Analysis 2030"
Get Free Access to Demo Report, Excel Pivot and ToC : https://www.insightaceanalytic.com/request-sample/1264…
Biospecimen Contract Research Services: Unlocking New Frontiers in Clinical Rese …
Global Biospecimen Contract Research Services Market is valued at US$ 4.38 Bn in 2023, and it is expected to reach US$ 11.70 Bn by 2031, with a CAGR of 13.37 % during the forecast period of 2024-2031.
Download Free Report Sample Pages: https://www.insightaceanalytic.com/request-sample/1264
Market Analysis:
Biospecimen Contract Research Services (BCRS) offer all-encompassing assistance with regard to the acquisition, manipulation, preservation, and dissemination of biological specimens intended for scientific investigation. Pharmaceutical companies, biotechnology…
Biospecimen Contract Research Services Market Surge: Key Developments and Foreca …
Biospecimen Contract Research Services Market is predicted to record a promising CAGR of 9.3% between 2024 and 2031.
InsightAce Analytic Pvt. Ltd. has announced the publication of a market research report titled " Global Biospecimen Contract Research Services Market (By Biospecimen Types(Oncological Studies, FFPE Tissue, Frozen Tissue, Plasma / Serum, Other Biospecimens, Non-Oncological Studies, Blood Products, Human Tissue, Other Biospecimens), Therapeutic Area(Oncological Disorders, Neurological Disorders, Cardiovascular Disorders, Other Therapeutic Areas))- Market…
